XML 26 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segmentation
3 Months Ended
Mar. 31, 2012
Business Segmentation [Text Block]
Note 9.   Business Segmentation
 
Since the year ended December 31, 2011, The Company has generated significant gross sales from our new retail dietary supplement product line, BluScience.  As a result, the Company has begun segregating its financial results into two reportable segments.
 
·  
Core standards, contract services and ingredients segment includes supply of phytochemical reference standards, which are small quantities of plant-based compounds typically used to research an array of potential attributes, and reference materials, related contract services, and proprietary ingredients.
 
·  
Retail dietary supplement products segment which consist of the supply of the BluScience line of dietary supplement products containing our proprietary ingredients to various retail distribution channels.
 
The “Other” classification includes corporate items not allocated by the Company to each reportable segment. Further, there are no intersegment sales that require elimination.  The Company evaluates performance and allocates resources based on reviewing gross margin by reportable segment. Information about reporting segment is provided below:

 
Three months ended March 31, 2012
 
Core Standards,
Contract Services and
Ingredients segment
   
Retail
Dietary Supplement
Products segment
   
Other
   
Total
 
                         
Gross Sales
  $ 1,871,718     $ 2,179,426     $ -     $ 4,051,144  
Promotions, discounts and returns
    (16,970 )     (2,249,168 )     -       (2,266,138 )
Net sales
    1,854,748       (69,742 )     -       1,785,006  
                                 
Cost of sales
    1,346,622       1,042,598       -       2,389,220  
                                 
Gross profit (loss)
    508,126       (1,112,340 )     -       (604,214 )
                                 
Operating expenses:
                               
Sales and marketing
    474,944       1,383,718       -       1,858,662  
General and administrative
    -       -       1,961,912       1,961,912  
Operating expenses
    474,944       1,383,718       1,961,912       3,820,574  
                                 
Operating income (loss)
  $ 33,182     $ (2,496,058 )   $ (1,961,912 )   $ (4,424,788 )
 
 
 
Three months ended April 2, 2011
 
Core Standards,
Contract Services and
Ingredients segment
   
Retail
Dietary Supplement
Products segment
   
Other
   
Total
 
                         
Gross Sales
  $ 2,541,580     $ -     $ -     $ 2,541,580  
Promotions, discounts and returns
    (2,335 )     -       -       (2,335 )
Net sales
    2,539,245       -       -       2,539,245  
                                 
Cost of sales
    1,518,850       -       -       1,518,850  
                                 
Gross profit
    1,020,395       -       -       1,020,395  
                                 
Operating expenses:
                               
Sales and marketing
    442,809       2,698       -       445,507  
General and administrative
    -       -       1,722,834       1,722,834  
Operating expenses
    442,809       2,698       1,722,834       2,168,341  
                                 
Operating income (loss)
  $ 577,586     $ (2,698 )   $ (1,722,834 )   $ (1,147,946 )
 
 
 
At March 31, 2012
 
Core Standards,
Contract Services and
Ingredients segment
   
Retail
Dietary Supplement
Products segment
   
Other
   
Total
 
                         
Total assets
  $ 3,358,441     $ 3,038,632     $ 6,527,472     $ 12,924,545  
 
 
 
At December 31, 2011
 
Core Standards,
Contract Services and
Ingredients segment
   
Retail
Dietary Supplement
Products segment
   
Other
   
Total
 
                         
Total assets
  $ 3,167,191     $ 1,470,268     $ 1,632,446     $ 6,269,905